GeneLink Former CEO's Lawsuit Dismissed | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A judge in the Superior Court of Pennsylvania has dismissed an appeal in a lawsuit by GeneLink's former CEO against the company, its GeneWize Life Sciences marketing subsidiary, and some of the company's executives, the company said today.

John DePhillipo, the former GeneLink CEO, had appealed a dismissal ruling handed down by the Court of Common Pleas of Pennsylvania, Philadelphia County, in May 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.